Invalidated Williams’ poison pill for violating core shareholder franchise rights
Plaintiff(s):
Shareholder plaintiff
Case type / claims:
Corporate governance action alleging breach of fiduciary duties and a challenge to the directors’ adoption of a “poison pill” rights plan that restricted shareholder communications among themselves and with management.
Defendant(s):
Board of Directors of The Williams Companies, Inc.
Jurisdiction
Delaware Chancery Court
Outcome:
- Won a landmark ruling declaring that Williams’ poison pill violated directors’ fiduciary duties and impermissibly restricted shareholder communications.
- Established that boards cannot use defensive measures to insulate themselves from shareholder accountability or suppress investor coordination.
- Reinforced Delaware’s strong protections for the shareholder franchise and set a key precedent limiting overreaching rights plans.
